Straddle Or Strangle?
When it comes to trading options, the straddle and the strangle are both profitable strategies – but each is best-suited for particular situations. CLICK HERE.
Stock Market
Untapped Opportunity In These Consumer Cyclicals
Goldman Sachs is especially bullish on the direction of the stock market this year – and sees a particular untapped opportunity in these 21 consumer… Read More »Untapped Opportunity In These Consumer Cyclicals
Shorts Of The Week
For investors interested in stocks on the way down, these two names are looking technically bearish – and could present interesting short opportunities. CLICK HERE.
The 22 Stocks With The Most New “Buy” Ratings
Analyst upgrades can help drive stock prices higher – and of all the stocks in the S&P 500, these 22 have seen the biggest increases… Read More »The 22 Stocks With The Most New “Buy” Ratings
A Packaged Preferred Stock Product With An Attractive Yield
While owning individual preferred stocks provides more stability, for a “packaged” preferred stock product, consider this actively managed ETF with an attractive 8.6% yield. CLICK… Read More »A Packaged Preferred Stock Product With An Attractive Yield
A Cancer Play With A New Treatment Paradigm – And Multiple Data Readouts This Year
Radiation, surgery, chemotherapy…and electric fields? This oncology company has developed a fourth paradigm for treating cancer – and has multiple data readouts this year that… Read More »A Cancer Play With A New Treatment Paradigm – And Multiple Data Readouts This Year
The Most Largely Undervalued Large-Cap Stock
This stock, just two-and-a-half months old, may be the most wildly undervalued large-cap stock on the market – and it’s expected to soon declare a… Read More »The Most Largely Undervalued Large-Cap Stock
These Big Tech Names Could Be About To Get A Lot Bigger
While tech stocks have been on an incredible run, and some are admittedly overvalued, big tech may be about to get even bigger – with… Read More »These Big Tech Names Could Be About To Get A Lot Bigger
A Way To Play This Vaccine Rollout Partnership
As has been on full display in recent weeks, developing an effective vaccine is one thing. Rolling it out efficiently is another. As one tech/industrial… Read More »A Way To Play This Vaccine Rollout Partnership
Better Times Ahead For Dividends: 10 Blue-Chips Hedge Funds Are Buying
After experiencing a terrible year due to the pandemic, the outlook for dividends appears much more positive in 2021 – and hedge funds are buying… Read More »Better Times Ahead For Dividends: 10 Blue-Chips Hedge Funds Are Buying